EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieBeobachtungsstudie

Echocardiographic risk stratification in heart failure with post-capillary pulmonary hypertension: prognostic value of LAVI and TAPSE/PASP

Emmanuelle Berthelot iD, Fabrice Bauer, Charles Fauvel, Marion Paclot, Jean-Christophe Eicher, Pascal de Groote iD, Jean-Noël Trochu, François Picard, Sébastien Renard, Hélène Bouvaist, Damien Logeart, François Roubille iD und 3 weitere

European Heart Journal - Cardiovascular Imaging · 2026

DOI: 10.1093/ehjci/jeag034 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Heart Journal - Cardiovascular Imaging, 2026. Verfasst von Emmanuelle Berthelot und 14 weiteren Autor:innen. Beteiligte Einrichtung: INSERM, UMR__S1358, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), AP-HP, Hôpital Bicêtre, Hôpital Marie Lannelongue …. Hauptthemen laut MEDLINE: Echocardiography, Heart Failure, Hypertension, Pulmonary. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Fédération Française de Cardiologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Post-capillary pulmonary hypertension (pcPH) is a frequent complication of heart failure (HF), associated with poor outcomes. While right heart catheterization (RHC) is the diagnostic gold standard, echocardiographic indices such as left atrial volume index (LAVI) and the TAPSE/PASP ratio may offer non-invasive prognostic value.

Objectives

To assess the prognostic utility of LAVI and TAPSE/PASP compared with invasive haemodynamic parameters in patients with HF and pcPH undergoing RHC. Methods and results The PH–HF study is a prospective multicentre cohort of adults with chronic HF and confirmed pcPH (mPAP > 20 mmHg and pulmonary arterial wedge pressure > 15 mmHg) enrolled across 13 French centres (2012–2018). Patients with precapillary PH or severe pulmonary/renal comorbidities were excluded. The primary outcome was a 3-year composite of all-cause mortality, urgent heart transplantation or LVAD, or unplanned HF hospitalization. Cox regression was used for survival analyses. Overall, 55% of patients met the composite echocardiographic risk criterion (LAVI > 35 mL/m² or TAPSE/PASP < 0.40), which was associated with increased risk of adverse events (HR 1.97, 95% CI 1.41–2.75; P < 0.0001). Results were consistent across HFrEF and HFpEF phenotypes. In a multivariable model including the MAGGIC score, both the echocardiographic criterion and the clinical score remained independently associated with outcomes, supporting their complementary value in risk stratification.

Conclusion

LAVI and TAPSE/PASP are strong, non-invasive predictors of adverse outcomes in HF with pcPH and may enhance prognostic assessment beyond invasive haemodynamics and clinical scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EchocardiographyHeart FailureHypertension, PulmonaryAgedFemaleHumansMaleMiddle AgedCardiac CatheterizationCohort StudiesFrancePrognosisProspective StudiesPulmonary Wedge PressureRisk Assessment

Stichwörter der Autor:innen

deathechocardiographyheart failurepost-capillary pulmonary hypertensionprognosispulmonary hypertension

Autor:innen und Institutionen

  • INSERM, UMR__S1358, Hypertension Pulmonaire: Physiopathologie et Innovation Thérapeutique (HPPIT), AP-HP, Hôpital Bicêtre, Hôpital Marie Lannelongue (Groupe Hospitalier Paris Saint Joseph), ERN-LUNG, FHU André Cournand,…
  • Service de Cardiologie, Hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France.
  • Département de Cardiologie, Hôpital Charles Nicolle, CHU de Rouen, Rouen, France.
  • Department of cardiologue, Centre de Compétence en Hypertension Pulmonaire 27/76, CHU de Rouen, Rouen, France.
  • INSERM U1096, Université de Rouen Normandie, Rouen, France.
  • Service de Cardiologie, CHU de Dijon-Hôpital François Mitterrand, Dijon, France.

ORCID-Profile: Emmanuelle Berthelot, Pascal de Groote, François Roubille, Nicolas Lamblin

Förderung

  • Fédération Française de Cardiologie

Zitieren

APA

Berthelot, E., Bauer, F., Fauvel, C., Paclot, M., Eicher, J. C., de Groote, P., Trochu, J. N., Picard, F., Renard, S., Bouvaist, H., Logeart, D., Roubille, F., Sitbon, O., Damy, T., & Lamblin, N. (2026). Echocardiographic risk stratification in heart failure with post-capillary pulmonary hypertension: prognostic value of LAVI and TAPSE/PASP. European Heart Journal - Cardiovascular Imaging. https://doi.org/10.1093/ehjci/jeag034

Vancouver

Berthelot E, Bauer F, Fauvel C, Paclot M, Eicher JC, de Groote P, et al. Echocardiographic risk stratification in heart failure with post-capillary pulmonary hypertension: prognostic value of LAVI and TAPSE/PASP. European Heart Journal - Cardiovascular Imaging. 2026. doi:10.1093/ehjci/jeag034

BibTeX
@article{Berthelot2026,
  author = {Berthelot, Emmanuelle and Bauer, Fabrice and Fauvel, Charles and Paclot, Marion and Eicher, Jean-Christophe and de Groote, Pascal and Trochu, Jean-Noël and Picard, François and Renard, Sébastien and Bouvaist, Hélène and Logeart, Damien and Roubille, François and Sitbon, Olivier and Damy, Thibaud and Lamblin, Nicolas},
  title = {Echocardiographic risk stratification in heart failure with post-capillary pulmonary hypertension: prognostic value of LAVI and TAPSE/PASP},
  journal = {European Heart Journal - Cardiovascular Imaging},
  year = {2026},
  doi = {10.1093/ehjci/jeag034}
}
Kostenlos starten →